Investigators from the UCLA Health Jonsson Comprehensive Cancer Center have identified a protein called UCHL1 in highly aggressive neuroendocrine carcinomas and neuroblastoma that could potentially be used as a molecular ...
Jan 29, 2024
0
28
Women using drugs and alcohol can feel stigmatized and shamed when seeking support from professional services, a new study has found.
Jan 19, 2024
0
0
Generative artificial intelligence could transform health care through things like drug development and quicker diagnoses, but the World Health Organization warned Thursday of the potential pitfalls in rushing to embrace ...
Jan 18, 2024
0
0
Wegovy, Ozempic and Mounjaro are weight loss and diabetes drugs that have made quite a splash in health news. They target regulatory pathways involved in both obesity and diabetes and are widely considered breakthroughs for ...
Jan 17, 2024
0
2
A population-based cohort study of more than 10,000 persons using gabapentinoids found that their use was associated with an increased risk of chronic obstructive pulmonary disease (COPD) exacerbation. This study supports ...
Jan 15, 2024
0
3
A new Cleveland Clinic study shows there are disparities in cancer research and advocacy funding and that less funding strongly correlates with fewer clinical trials in a particular disease.
Jan 9, 2024
0
0
Dutch scientists have discovered five biological variants of Alzheimer's disease, which may require different treatments. As a result, previously tested drugs may incorrectly appear to be ineffective or only minimally effective. ...
Jan 9, 2024
2
100
Researchers have identified new antibiotic molecules that target Mycobacterium tuberculosis and make it less pathogenic for humans. In addition, some of the discovered substances may allow for a renewed treatment of tuberculosis ...
Jan 4, 2024
0
49
A team of anesthesiologists at the University of Michigan, working with a pair of colleagues from Tryp Therapeutics, has found, via experimentation, that rats can experience a reduction in chronic pain when given injections ...
In a novel study, researchers from the Icahn School of Medicine at Mount Sinai have introduced LoGoFunc, an advanced computational tool that predicts pathogenic gain and loss-of-function variants across the genome.
Dec 14, 2023
0
21
